Original Article
Neuropsychopharmacology (2006) 31, 204–211. doi:10.1038/sj.npp.1300856; published online 3 August 2005
Clinical Research
The Mu-Opioid Receptor Polymorphism A118G Predicts Cortisol Responses to Naloxone and Stress
Rachel Y Chong1, Lynn Oswald2, Xiaoju Yang1, Magdalena Uhart1, Ping-I Lin3 and Gary S Wand1,2
- 1Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
- 2Department of Psychiatry, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
- 3Center for Human Genetics, Duke University Medical Center, Durham, NC, USA
Correspondence: Dr GS Wand, Departments of Medicine and Psychiatry, The Johns Hopkins University School of Medicine, Ross Research Building, Room 863, 720 Rutland Avenue, Baltimore, MD 21205, USA. Tel: +1 410 955 7225; Fax: +1 410 955 0841; E-mail: gwand@jhmi.edu
Received 28 March 2005; Revised 13 June 2005; Accepted 13 June 2005; Published online 3 August 2005.
Abstract
A polymorphism in the mu-opioid receptor (MOR) (A118G) has been shown to increase
-endorphin binding affinity, theoretically placing greater inhibitory tone on hypothalamic corticotropin-releasing hormone (CRH) neurons. We hypothesized that the minor allele (G) would predict cortisol responses to both pharmacological (naloxone) and psychological (stress) activation of the hypothalamic–pituitary–adrenal (HPA) axis. Healthy subjects (mean age 25.2 years, SD 9.2 years) completed a naloxone challenge (n=74) and/or the modified Trier Social Stress Test (TSST) (n=86). For the naloxone challenge, two baseline blood samples were obtained. Then, five increasing doses of i.v. naloxone were administered at 30-min intervals and 12 additional blood samples were collected at 15-min intervals. The TSST consisted of 5-min of public speaking and 5-min of mental arithmetic exercises. Three baseline and five post-TSST blood samples were drawn. Both the naloxone and TSST groups had significant adrenocorticotropin (ACTH) and cortisol responses to their respective challenges (P<0.001). There were no differences in baseline ACTH, baseline cortisol, or ACTH response by genotype in either the naloxone or the TSST group. Among subjects expressing a G allele, there was a higher cortisol response to naloxone (P=0.046), but a lower cortisol response to the TSST (P=0.044). In conclusion, the minor allele (G) was associated with a robust cortisol response to naloxone blockade, but a blunted response to psychosocial stress. We speculate that increased opioid avidity of the minor allele receptor contributes to the differential response to naloxone vs stress.
Keywords:
adrenocorticotropin, cortisol, naloxone, opioid receptor, polymorphism, stress
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Development of pharmacotherapies for drug addiction: a Rosetta Stone approach
Nature Reviews Drug Discovery Review (01 Jun 2009)
RESEARCH
Neuropsychopharmacology Original Article
Neuropsychopharmacology Original Article
Neuropsychopharmacology Original Article
Hormonal Responses to Psychological Stress and Family History of Alcoholism
Neuropsychopharmacology Original Article

